Related by context. All words. (Click for frequent words.) 74 erythematosus 74 Acute Renal Failure 73 Chronic lymphocytic leukemia 73 Systemic lupus erythematosus SLE 73 Exacerbations 73 complement inhibitor eculizumab 73 Myelofibrosis 73 NOMID 73 Acute Bacterial Sinusitis ABS 73 Non Alcoholic Steatohepatitis 73 Acute Exacerbations 72 Allergic Rhinitis 72 Oral Fingolimod 72 Chronic Sinusitis 72 Lupus Nephritis 72 Chemotherapy induced 72 Chronic Bronchitis 72 essential thrombocythemia ET 72 Leukemias 72 progressive neurodegenerative disorder 72 Lymphocytic 72 severe malignant osteopetrosis 72 Idiopathic Pulmonary Fibrosis 71 Atypical Hemolytic Uremic Syndrome 71 Overactive Bladder 71 Nonalcoholic Fatty Liver Disease 71 Severe Sepsis 71 Investigational Treatment 71 atypical Hemolytic Uremic Syndrome 71 cystic fibrosis chronic pancreatitis 71 AAT deficiency 71 Acute myeloid leukemia 71 PsA 71 myelodysplastic myeloproliferative diseases 71 psoriatic arthritis PsA 71 Polyneuropathy 71 induce orthostatic hypotension 71 HeFH 70 TTR amyloidosis 70 Non Alcoholic Fatty 70 dual endothelin receptor antagonist 70 AA Amyloidosis 70 Idiopathic pulmonary fibrosis 70 Soft Tissue Sarcoma 70 Systemic Sclerosis 70 lupus erythematosus 70 Keratitis 70 chronic eosinophilic leukemia 70 chronic rheumatic 70 Thromboembolic 70 Hypertrophic 70 Atopic Dermatitis 70 Safinamide 70 hyperphenylalaninemia HPA due 70 Neovascular Age Related Macular 70 leukemia AML 70 Chronic Heart Failure 70 Nonalcoholic fatty liver 70 bullous 70 headache abdominal pain 70 Candidiasis 70 ADPKD 70 systemic juvenile idiopathic 69 INSPIRE Trial Phase III 69 cytomegalovirus infection 69 metastatic neuroendocrine tumors 69 ANCA associated 69 Critical Limb Ischemia CLI 69 hypereosinophilic syndrome 69 AAT Deficiency 69 Venous thromboembolism 69 FDA APPROVES 69 Relapsing Multiple Sclerosis 69 toenail onychomycosis 69 Ischemic 69 Bipolar Mania 69 Severe Primary IGFD 69 Chronic Prostatitis 69 Idiopathic Pulmonary Fibrosis IPF 69 Complicated Skin 69 Meets Primary Endpoint 69 systemic autoimmune 69 Multiple sclerosis MS 69 Mucositis 69 IN PATIENTS WITH 69 Basal Cell 69 LHON 69 Irritable Bowel Syndrome IBS 69 Juvenile Idiopathic Arthritis JIA 69 rare autosomal recessive 69 Major depressive disorder 69 debilitating autoimmune 69 Treating Chronic 69 Adenomas 69 Phase 2b Trial 69 Chronic Obstructive Pulmonary 69 Ulcerative colitis 69 dominantly inherited 69 Squamous 69 Phase 2b Clinical Trial 69 Ribavirin causes 69 Treatment Resistant 69 Etanercept 69 metastatic malignant 69 subependymal giant cell 69 Chronic Myeloid Leukemia 69 Aortic stenosis 69 Systemic lupus erythematosus 69 Advanced Melanoma 69 Atopic dermatitis 69 Herpes zoster 68 Interstitial cystitis 68 Diabetic Neuropathy 68 Juvenile Idiopathic Arthritis 68 Prolongs Survival 68 Malignant Melanoma 68 MELAS 68 Severe Asthma 68 systemic lupus erythematosus psoriasis 68 Hereditary angioedema HAE 68 leiomyomas 68 chronic immune thrombocytopenic 68 Tardive dyskinesia 68 Initiates Clinical Trial 68 familial amyloidotic polyneuropathy FAP 68 Morquio 68 autosomal recessive disorder 68 Hormone Refractory Prostate Cancer 68 Subarachnoid hemorrhage 68 transthyretin TTR mediated amyloidosis 68 Chronic Myelogenous Leukemia 68 Inhaled Corticosteroids 68 Chemotherapy Induced 68 Relapsing Remitting Multiple Sclerosis 68 Rheumatoid 68 NASH Huntington 68 overactive bladder syndrome 68 Cystic 68 myocardial infarction ventricular fibrillation 68 Nilotinib 68 Hyperkalemia 68 Fabry Disease 68 Cutaneous T 68 Fungal Infections 68 myeloproliferative neoplasms 68 lichen planus 68 Systemic Lupus Erythematosus SLE 68 post transplant lymphoproliferative 68 Psoriatic arthritis 68 Angioedema 68 reflux disease GERD 68 underlying vasculopathy 68 Adjunctive Therapy 68 Mouse Model 68 1 Antitrypsin Deficiency 68 Pulmonary Arterial Hypertension 68 Bronchiolitis 68 progressive neurodegenerative 68 bronchial hyperresponsiveness 68 Improves Outcomes 68 Benign prostatic hyperplasia BPH 68 systemic fungal infections 68 Patients Receiving 68 Major Depressive Disorder MDD 68 benign prostatic hypertrophy BPH 68 erythema nodosum 68 severe obstructive pulmonary 68 juvenile idiopathic arthritis 68 hyperplasia BPH 68 Plaque Psoriasis 68 Novel Oral 68 Unresectable 68 Lupus nephritis 68 Pleural Mesothelioma 68 J Am Coll 68 Myelodysplastic Syndrome 68 cell lymphoma CTCL 68 Chronic Lymphocytic Leukemia 68 Diabetic Macular Edema 68 Ankylosing spondylitis 68 Serious Infections 68 INTEGRILIN R 68 SNT-MC#/idebenone 68 Adjunctive 68 Chronic HCV 68 Resistant Hypertension 68 CYT# potent vascular disrupting 68 AVAPRO 68 NAGS deficiency 68 Pooled Analysis 67 Follicular Lymphoma 67 Congenital Emphysema 67 Community Acquired Pneumonia 67 neurological manifestations 67 Chronic constipation 67 Myelodysplastic Syndrome MDS 67 included exfoliative dermatitis 67 Pulmonary hypertension 67 Golimumab 67 recurrent glioblastoma multiforme 67 Chronic Renal Failure 67 HIV HCV coinfected 67 debilitating complication 67 Iron Deficiency Anemia 67 Retinopathy 67 Peripheral artery disease 67 Comorbidities 67 Diabetic nephropathy 67 disease GERD 67 invasive aspergillosis 67 Gliomas 67 Philadelphia Chromosome Positive 67 Ranolazine 67 induced macular edema 67 Malignant Glioma 67 Secondary Hyperparathyroidism 67 Crit Rev 67 Myelodysplastic syndromes MDS 67 thrombocytopenia neutropenia 67 arthritis PsA 67 Subgroup Analysis 67 Hypertriglyceridemia 67 Pemphigus 67 chronic myeloid 67 Hypercholesterolemia 67 Preclinical Models 67 Natalizumab 67 See CLINICAL PHARMACOLOGY 67 receiving VELCADE 67 Extensively drug 67 hyperprolactinemia 67 hay fever allergic rhinitis 67 Onychomycosis 67 chronic thromboembolic pulmonary 67 hyperammonemia 67 Idiopathic 67 leukoencephalopathy 67 Oral mucositis 67 Relapsed Refractory 67 SSc 67 chronic granulomatous disease 67 Esophageal 67 Tiotropium 67 Rhinosinusitis 67 Iron Overload 67 myoclonus 67 Cholangiocarcinoma 67 Chronic Hepatitis B 67 Critical limb ischemia 67 idiopathic pulmonary fibrosis IPF 67 Drug Candidate 67 Receives Orphan Drug Designation 67 ATTR PN 67 PAOD 67 SGPT 67 Esophagitis 67 metastatic gastric 67 vWD 67 Glioblastoma Multiforme 67 treat benign prostatic 67 oropharyngeal candidiasis OPC 67 esophageal candidiasis 67 Naive Patients 67 Sezary syndrome 67 J Am Acad 67 SJIA 67 Chronic Lung 67 Polycystic ovary syndrome PCOS 67 Immune Mediated 67 juvenile myoclonic epilepsy 67 Dupuytren Contracture 67 Prophylactic Treatment 67 Schizoaffective Disorder 67 Asymptomatic 67 anterior uveitis 67 Endometrial cancer 67 Decitabine 67 multisystem disease 67 cheilitis 67 clinically heterogeneous 67 inflammatory demyelinating 67 ATTR CM 67 ankylosing spondylitis AS 67 Denufosol 67 Chronic Inflammatory 67 homozygous familial hypercholesterolemia 67 dermatologic reactions 67 Elderly Patients 67 relapsing multiple sclerosis 67 Hyperlipidemia 67 Tardive Dyskinesia 67 Gastrointestinal GI 67 Bronchopulmonary Dysplasia 67 Growth Hormone Deficiency 67 bacterial vaginosis BV 67 Papillary 67 malignant pleural effusion 67 Clinical Trial Results 66 Catheter Associated 66 Generalized Anxiety Disorder 66 Major Depressive Disorder 66 Platinol ® 66 1 proteinase inhibitor 66 Adjuvant Treatment 66 Septic Shock 66 exocrine pancreatic insufficiency EPI 66 Hemorrhagic 66 Acute Decompensated Heart Failure 66 cause cardiac channelopathies 66 atypical hemolytic uremic syndrome 66 fatal neurodegenerative disorder 66 TNF Tumor Necrosis Factor 66 Rheumatoid arthritis RA 66 Retinitis Pigmentosa RP 66 Drug Prevents 66 proliferative diabetic retinopathy 66 Oral Mucositis 66 Cognitive Impairment 66 Escherichia coli Klebsiella pneumoniae 66 Antitumor Activity 66 Sevelamer 66 Meningiomas 66 Comorbid 66 included neutropenia anemia 66 Obstructive sleep apnea OSA 66 Myelodysplastic Syndromes 66 constipation predominant irritable bowel 66 Generalized anxiety disorder 66 carcinoid tumors 66 Drug Resistant 66 Hsp# Inhibitor 66 kidney urologic 66 neutropenia dehydration dyspnea 66 Hepatocellular Carcinoma 66 Eisenmenger syndrome 66 relapsed MM 66 osteoporotic vertebral fractures 66 rhinitis sinusitis 66 Chronic sinusitis 66 acetonide FA 66 Carcinoid tumors 66 B Cell Lymphoma 66 familial hypercholesterolemia 66 CP CPPS 66 Thrombocytopenia 66 Slow Progression 66 Warfarin Coumadin 66 peritumoral brain edema 66 Novel Treatments 66 By JENNIFER LEARN 66 Premature Infants 66 Hepatotoxicity 66 Respiratory Infections 66 See WARNINGS 66 Streptococcus pneumoniae Haemophilus influenzae 66 anticholinergic agents 66 Demonstrates Efficacy 66 Treatment Shows Promise 66 Inflammatory Markers 66 heparin induced thrombocytopenia 66 Respiratory syncytial virus RSV 66 Diabetic Foot Ulcer 66 Eosinophilic 66 CTAP# 66 Acute Heart Failure 66 known teratogen substance 66 Chronic Fatigue Syndrome CFS 66 macular edema secondary 66 asthma rhinitis 66 Chronic Kidney 66 Periodontitis 66 pemphigus vulgaris 66 Chronic Insomnia 66 Hemophilia B 66 HBeAg negative 66 Malignancies 66 Benign Prostatic Hyperplasia BPH 66 Chronic Pelvic Pain 66 polycythemia vera essential thrombocythemia 66 Metastases 66 candidemia 66 atrophic gastritis 66 Controlled Trial 66 Pediatric Patients 66 Autoimmune Diseases 66 Systemic Lupus Erythematosus 66 Sjogren Syndrome 66 Renal dysfunction 66 Trigeminal Neuralgia 66 occlusion CRVO 66 Knee Osteoarthritis 66 rheumatoid arthritis psoriatic arthritis 66 C1 INH deficiency 66 polymyalgia rheumatica 66 hypertrichosis occurred 66 vaginal candidiasis 66 hepatorenal syndrome 66 Newly Diagnosed Multiple Myeloma 66 J Shoulder Elbow 66 Patients Treated With 66 tuberous sclerosis complex 66 Seborrheic dermatitis 66 Acute Myeloid Leukaemia AML 66 Familial Adenomatous Polyposis FAP 66 Enzyme Replacement Therapy 66 idiopathic generalized epilepsy 66 Tigecycline 66 neurogenic bladder 66 ceroid lipofuscinosis NCL 66 proliferative retinopathy 66 systemic lupus erythematosus SLE 66 hereditary antithrombin deficiency 66 Atrophic 66 diabetic gastroparesis 66 Leber Hereditary Optic Neuropathy 66 INCB# [003] 66 Hydroxyurea 66 Previously Treated 66 Dermatol 66 Bacterial Vaginosis 66 Pivotal Phase III 66 Demonstrates Positive 66 familial adenomatous polyposis 66 Frontotemporal Dementia 66 Respiratory Distress 66 Refractory Hodgkin Lymphoma 66 Mitral Regurgitation 66 gastrointestinal dysfunction 66 Long Term Efficacy 66 Graft Versus Host 66 Diabetic Nephropathy 66 Diabetic Neuropathic Pain 66 Phase 2a Clinical Trial 66 primary Restless Legs 66 torsade de pointes 66 alpha1 antitrypsin deficiency 66 ST Segment Elevation 66 Infusion Reactions Severe 66 Pervasive Developmental Disorders 66 Deferiprone 66 hemorrhagic cystitis 66 acute febrile 65 relapsing remitting MS RRMS 65 active ankylosing spondylitis 65 Atherosclerotic 65 Am J Clin 65 Diabetes mellitus 65 Rheumatoid Arthritis RA 65 invasive candidiasis 65 SPRYCEL ® 65 Lymphoid 65 See CONTRAINDICATIONS 65 ulcerative colitis Crohn disease 65 diaper dermatitis 65 acute PAO 65 TNF Blockers 65 Progressive Multifocal Leukoencephalopathy 65 Castration Resistant Prostate Cancer 65 Subclinical 65 FDA Approves Drug 65 chronic idiopathic thrombocytopenic purpura 65 Lambert Eaton Myasthenic 65 Sleep Disturbances 65 Uterine Fibroids 65 Heart Failure Patients 65 Combination Treatment 65 Autoantibodies 65 Candida infections 65 idiopathic thrombocytopenic purpura ITP 65 Irritable bowel syndrome 65 Renal Impairment 65 Generalized Anxiety Disorder GAD 65 Epstein Barr Virus 65 Iron Deficiency 65 purpura ITP 65 pancytopenia 65 ACE Inhibitors 65 Maven Semantic 65 Treated Patients 65 Melasma 65 urticaria hives 65 Successfully Completes Phase 65 severe oral mucositis 65 Enlarged Prostate 65 Central Retinal Vein 65 von Willebrand Disease 65 hypophosphatasia 65 Polycythemia Vera 65 Often Misdiagnosed 65 purpura 65 congenital ichthyosis 65 Glioma 65 transthyretin amyloidosis 65 nonbacterial prostatitis 65 pulmonary alveolar 65 Dysplasia 65 leukemia ALL 65 bacterial prostatitis 65 Respiratory Syncytial Virus 65 Spasticity 65 myeloproliferative disorders 65 relapsed leukemia 65 Hormone Receptor Positive 65 Vulvar 65 superficial basal cell carcinoma 65 primary immunodeficiency PI 65 Nebulized 65 Randomized Double blind 65 Study Evaluating 65 Clostridium Difficile Associated 65 gastrointestinal reflux 65 Essential Tremor 65 Rheumatoid Arthritis Patients 65 idiopathic thrombocytopenic purpura 65 candidiasis 65 bronchogenic carcinoma 65 Renal Artery 65 Pulmonary Arterial Hypertension PAH 65 Pemetrexed 65 Delayed Graft Function 65 Endocarditis 65 primary hyperparathyroidism 65 Research www. elsevier.com 65 Candida infection 65 immunocompetent patients 65 JAK2 Inhibitor 65 Primary IGFD 65 Peripheral Arterial 65 hypovitaminosis D 65 TREATMENT OF 65 Psoriatic Arthritis 65 Seasonal Allergic Rhinitis 65 Thiazolidinediones 65 Clinical Outcome 65 pulmonary hypertension PH 65 cystic fibrosis bronchiectasis 65 Prospective Randomized 65 MPS VI 65 adenomatous 65 Tyrosine Kinase Inhibitor 65 Lowers Risk 65 Chronic Hepatitis C 65 Ischaemic heart 65 Hypoactive Sexual Desire Disorder 65 interstitial cystitis IC 65 osteoporotic vertebral compression fractures 65 Acne Rosacea 65 giant cell arteritis 65 Fibrosis 65 systemic lupus erythematosus 65 Mild Cognitive Impairment 65 Urinary tract 65 Thromboembolism 65 autoimmune thyroid 65 Orthop Surg 65 diabetes mellitus DM 65 Cytomegalovirus 65 Visceral leishmaniasis 65 neurological disorder affecting 65 Initiates Phase II 65 CTEPH 65 Rhinitis 65 Medulloblastoma 65 myofascial pain syndrome 65 autosomal recessive genetic 65 benign prostatic hypertrophy 65 beta 1a 65 constipation OIC 65 Peginterferon 65 constipation IBS C 65 Peripheral Artery Disease 65 pouchitis 65 developing Bicifadine serotonin 65 Double Blind Randomized 65 fungoides 65 Pulmonary Embolism PE 65 Squamous Cell Carcinoma 65 neurobehavioral disorder 65 Inhaled Nitric Oxide 65 post herpetic 65 Levels Linked 65 Fibromyalgia Syndrome 65 Pirfenidone 65 Atopic eczema 65 Hypotension 65 Eculizumab 65 Parkinson Disease PD 65 hypoparathyroidism 65 Glioblastoma Multiforme GBM 65 dasatinib Sprycel ® 65 venous stasis ulcers 65 Novel Mechanism 65 Slows Progression 65 juvenile idiopathic arthritis JIA 65 Thrombotic 65 diarrhea predominant irritable 65 Idiopathic Thrombocytopenic Purpura ITP 65 Hematologic 65 Interferon Beta 65 autosomal dominant polycystic kidney 65 Nocturia 65 Mg Usa 65 Chronic Lymphocytic Leukemia CLL 65 rheumatic disease 65 Renal Anemia 65 Interstitial Cystitis 65 Etiology 65 chronic rhinosinusitis CRS 65 Phase IIb Clinical Trial 65 Trial Evaluating 65 neuropsychiatric disorder 65 acute myeloid 65 Diabetic Retinopathy 65 simplex virus 65 Adjuvant Chemotherapy 65 Gene Mutation Linked 65 First Patient Enrolled 65 Langerhans cell histiocytosis 65 R lenalidomide 65 Randomized Study 65 Ankylosing Spondylitis 65 overactive bladder OAB 65 Asthma COPD 65 Successfully Treated 65 transplantation HCT 65 Advanced Renal Cell 65 Exacerbation 65 Renal Function 65 treat chronic sinusitis 65 Paroxysmal Nocturnal Hemoglobinuria PNH 65 including thyroiditis RA 65 Lubiprostone 65 Otitis Media 65 PEGylated anti 65 Peritonitis 65 Shows Promise Against 65 Gene Linked 65 Irritable bowel syndrome IBS 65 Autoimmune Disease 65 diabetes dyslipidemia 65 Subtypes 65 post herpetic neuralgia PHN 65 Myasthenia gravis 65 Protein Linked 65 Irritable Bowel 65 Heterozygous Familial Hypercholesterolemia 65 Polymorphic Ventricular Tachycardia CPVT 65 Services #:#-#,# Abstract 65 non splenectomized 65 FluCAM arm 65 gastro oesophageal reflux 65 Minimally Invasive Treatment 65 Carcinoid 65 Ovarian cysts 65 Single Dose 65 syndrome RLS 65 AVONEX ® 65 neutropenia thrombocytopenia 65 Metastatic Colorectal Cancer 65 nephropathic cystinosis 65 hepatocellular carcinoma liver 65 minimally symptomatic 65 MKC# MT 65 erlotinib Tarceva ® 65 Psychiatric Disorders 64 Chronic Rhinosinusitis 64 nonalcoholic steatohepatitis 64 posterior uveitis 64 Sapacitabine 64 Benign Prostatic Hyperplasia 64 Chronic obstructive pulmonary 64 Antiviral Therapy 64 PEGylated interferon beta 1a 64 acute humoral rejection 64 Actinic Keratosis 64 Anaplastic 64 Increased Mortality 64 hereditary degenerative 64 thyrotoxicosis 64 Anthracycline 64 Postherpetic Neuralgia 64 Liver Injury 64 Completes Patient Enrollment 64 Granted Orphan Drug 64 Overactive Bladder OAB 64 Hypospadias 64 Restless Legs Syndrome RLS 64 Ascites 64 C. trachomatis 64 Phase III Clinical Trial 64 Gastroesophageal Reflux Disease 64 Unstable Angina 64 Infantile Spasms 64 Fatty liver 64 Voreloxin 64 #-# Full Text 64 refractory chronic lymphocytic 64 CRVO 64 discoid lupus 64 tuberous sclerosis TS 64 Patient Registry 64 Tuberous sclerosis 64 Diabetic neuropathy 64 Phase IIa Clinical Trial 64 Pafuramidine 64 myelofibrosis polycythemia vera 64 Acute Coronary 64 R Saizen R 64 Autistic Disorder 64 Lamotrigine 64 Peripheral arterial disease 64 Myeloid 64 bexarotene 64 Hospital Acquired Pneumonia 64 Combination REOLYSIN R 64 Polymorphisms 64 Phase 2a Trial 64 Nephropathy 64 acute porphyria 64 sJIA 64 Primary Hypercholesterolemia 64 Arrhythmias 64 aMCI precursor 64 Vulvodynia 64 systolic hypertension 64 INVEGA ® 64 collagen vascular 64 Peginterferon alfa 2b 64 chronic myocardial ischemia 64 Lennox Gastaut Syndrome 64 Peripheral neuropathy 64 Limb Ischemia 64 J Allergy Clin 64 Skin Structure Infections 64 ST Elevation Myocardial 64 recurrent glioma 64 J Foot Ankle 64 Female Sexual Arousal 64 Prostatitis 64 receiving XGEVA 64 Completes Enrollment 64 Paroxysmal 64 Renal Cell Carcinoma 64 Acidosis 64 Hepatic Encephalopathy 64 erythematosus SLE 64 Hodgkin lymphoma HL 64 Acute Myelogenous Leukemia 64 Lymphomas 64 metastatic GIST 64 Henoch purpura 64 Neutropenia 64 somatostatin analog 64 Initiate Phase 64 Erythropoietic 64 von Hippel Lindau 64 cholangiocarcinoma 64 Free Full Text 64 Teva Provides Update 64 autoantibody positive 64 Reduces Mortality 64 rheumatic disorders 64 Mantle Cell Lymphoma 64 Phase Ib Clinical Trial 64 Maroteaux Lamy syndrome 64 Metastatic Prostate Cancer 64 ara C 64 Intracerebral 64 Advanced Pancreatic Cancer 64 Amgen Neulasta R 64 Placebo Controlled Study 64 Cognitive Deficits 64 Ophena TM 64 Shows Efficacy 64 unknown etiology 64 PEGylated Fab fragment 64 Decompensated 64 predominantly classic subfoveal 64 colorectal carcinoma 64 Microplasmin 64 choroidal neovascularization 64 Pelvic Organ Prolapse 64 Arch Facial Plast 64 hypercalcaemia 64 Relapsing remitting MS 64 Prognostic Factors 64 basal cell carcinoma BCC 64 abacavir Ziagen 64 Investigational Compound 64 Adenocarcinoma 64 URG# targets 64 Rare Genetic 64 polyarticular 64 FOLOTYN ® 64 Phase 2b Study 64 BUPHENYL 64 Fingolimod 64 Social Phobia 64 chronic hepatitis cirrhosis 64 Chronic Myelogenous Leukemia CML 64 polycythemia vera PV 64 Oropharyngeal Candidiasis 64 systemic corticosteroid 64 non alcoholic steatohepatitis 64 selective modulator 64 Reminyl galantamine 64 Phase III Trial 64 #:#-# [031] 64 DPNP 64 terlipressin 64 smoldering myeloma 64 Tolvaptan 64 ATTR 64 Diabetic Foot Ulcers 64 Myocarditis 64 malignant neoplasm 64 Lung Injury 64 deletion 5q 64 acute GvHD 64 secondary hyperparathyroidism 64 Nephrogenic 64 Gastroparesis 64 Combo Therapy 64 Gastroesophageal reflux disease 64 unstable angina pectoris 64 Valvular 64 rheumatoid arthritis inflammatory bowel 64 Benign prostatic hyperplasia 64 herpes zoster shingles 64 proctitis 64 cystoid macular edema 64 Stomatitis 64 Kit CD# positive 64 Demonstrates Sustained 64 thetreatment 64 peripheral arterial occlusive disease 64 Faropenem 64 MKC# MKC# PP 64 malignant pleural mesothelioma MPM 64 Encephalopathy 64 pathologic myopia 64 G6PD deficiency 64 Initiates Enrollment 64 Bacteremia 64 essential thrombocythemia 64 IGFD 64 Chronic Constipation 64 salmeterol fluticasone 64 Pivotal Trial 64 J Clin 64 Pulmonary Hypertension 64 Parathyroid 64 carcinoid syndrome 64 #:#-# [023] 64 Newly Diagnosed Patients 64 IPAH 64 Diffuse Large B 64 Acute Bacterial Skin 64 syndrome gastroesophageal reflux 64 lupus nephritis 64 cirrhosis liver failure 64 Vitrasert R 64 1 antitrypsin AAT 64 Severe cutaneous 64 rheumatoid arthritis osteoarthritis ankylosing 64 Moxifloxacin 64 diseases chronic granulomatous 64 inherited retinal degeneration 64 Magnesium deficiency 64 herpetic keratitis 64 Sleep Disordered Breathing 64 Pulmonary arterial hypertension 64 Chronic bronchitis 64 Refractory Angina 64 ALN HPN 64 Prostatic 64 Postherpetic neuralgia 64 acute leukemias 64 immune thrombocytopenic purpura 64 systemic scleroderma 64 SHPT 64 Acute Radiation Syndrome ARS 64 Adenoma 64 Acid reflux disease 64 AA amyloidosis 64 T1DM 64 Dupuytren Disease 64 Obstructive Sleep Apnea 64 Kuvan sapropterin dihydrochloride 64 Obstructive Sleep Apnoea 64 IND Application 64 enterocolitis 64 Pancreatic 64 Aflibercept 64 neovascular diseases 64 Ceflatonin R 64 Rivastigmine 64 recurrent sinusitis 64 LENALIDOMIDE 64 inherited neurodegenerative 64 Pivotal Clinical Trial 64 diarrhea vomiting rash 64 CLINICAL PHARMACOLOGY 64 Pharmacologic 64 Initiates Phase III 64 Hyperthyroidism 64 rheumatoid arthritis systemic lupus 64 Pegloticase 64 Non inferiority 64 Efficacious 64 Drug Shows Promise 64 uricase 64 Host Disease GvHD 64 haloperidol Haldol 64 Dyskinesia 64 Xerostomia 64 Immunotherapeutic 64 brand ciclesonide HFA 64 Pompe Disease 64 cerebrovascular disorders 64 Pleural mesothelioma 64 congenital deficiency 64 Trandolapril 64 Fatty Liver Disease 64 optic neuropathy 64 tics involuntary 64 Hepatocellular 64 cancerous enlargement 64 Ischemic Stroke 64 GW# [003] 64 Patients Suffering 64 advanced hepatocellular carcinoma 64 common hematologic malignancy 64 Chronic lymphocytic leukemia CLL 64 Pelvic Inflammatory Disease 64 Emerging Therapies 64 BCG refractory carcinoma 64 neuromuscular spasm 64 Orthostatic Hypotension 64 FASEB J. 64 Daclizumab 64 Carcinomas 64 recurrent glioblastoma 64 aripiprazole Abilify 64 Pharmacokinetics PK 64 ichthyosis vulgaris 64 paroxysmal nocturnal hemoglobinuria 64 Non Invasive Treatment 64 Osteomyelitis 64 Hematological 64 autoinflammatory diseases 64 autosomal recessive disease 64 recurrent malignant glioma 64 Aryplase 64 gastro esophageal reflux disease 64 CYP#A# substrate 63 Suicidality 63 nonalcoholic steatohepatitis NASH 63 Replacement Therapy 63 rheumatologic 63 hepatic failure 63 aortic valve stenosis 63 hyperparathyroidism 63 Mylan Receives Approval 63 myeloproliferative diseases 63 Metastatic Melanoma 63 Epratuzumab 63 Alzheimer Disease AD 63 Kamada AAT 63 metabolic alkalosis 63 Curr Opin 63 Tasimelteon 63 Beclomethasone 63 Toxicities 63 muscular dystrophy cystic fibrosis 63 reduce serum phosphate 63 Cutaneous 63 smoldering multiple myeloma 63 Gastric Cancer 63 Depressive Disorder 63 Initiates Phase 2b 63 Adalimumab 63 NSAID induced 63 Frozen Shoulder Syndrome 63 HBeAg + 63 Carcinoma 63 Respiratory Syncytial Virus RSV 63 Parnate 63 Liver Failure 63 Nephrol Dial Transplant 63 chronic neurological disorder 63 Cervical Disease 63 progressive dyspnea 63 HDAC Inhibitor 63 cramping abdominal pain 63 Multiple Myeloma MM 63 castrate resistant prostate cancer 63 HoFH 63 rheumatoid arthritis RA psoriatic